GET DAILY SIGNALSValhi (VHI) Delivers Turnaround with $1.06 EPS in Q3 2026
Key Takeaways
- Valhi reported net income attributable to stockholders of $30.2 million, or $1.06 per share, for the third quarter of 2026, reversing a loss of $0.78 per share in the year-ago period.
- The chemicals segment swung to $60.5 million in operating income, compared with a $15.9 million loss a year earlier, on higher titanium dioxide (TiO2) prices and market-share gains.
- Total net sales climbed to $589.0 million, up from $503.5 million in the third quarter of 2025.
- Nine-month net income attributable to Valhi reached $54.5 million, or $1.91 per share, versus a loss of $0.15 per share in the first nine months of 2025.
- Results included a non-cash deferred tax benefit of roughly $0.28 per share tied to proposed currency regulations, a one-time item investors should consider when assessing core performance.
Earnings Context and Why It Matters
Valhi, Inc. is a diversified holding company whose principal business is the production and sale of titanium dioxide (TiO2) pigments through its majority-owned subsidiary Kronos Worldwide, alongside component products and real estate operations. Because chemicals dominate the revenue mix, TiO2 pricing and demand are the key swing factors in any quarter. After a difficult stretch in which the chemicals segment posted losses, this report marks a decisive shift toward profitability, driven by price increases, market-share gains in Europe and North America, and anti-dumping duties in select markets. For investors, the quarter signals whether the cyclical recovery in TiO2 is translating into sustainable earnings rather than one-off gains, making this an important checkpoint for the company's momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
For the third quarter of 2026, Valhi reported net income attributable to stockholders of $30.2 million, or $1.06 per share, compared with a net loss of $22.2 million, or $0.78 per share, in the third quarter of 2025. The result came in ahead of the roughly $0.85 consensus earnings per share (EPS) estimate tracked by analysts.
Total net sales rose to $589.0 million, up from $503.5 million a year earlier. The chemicals segment led the improvement, with net sales up 18% to $541.1 million and operating income of $60.5 million versus a $15.9 million loss a year ago. Component products net sales increased to $44.0 million with operating income of $6.4 million, while real estate management and development net sales declined to $3.9 million.
For the first nine months of 2026, net income attributable to Valhi totaled $54.5 million, or $1.91 per share, compared with a loss of $4.4 million, or $0.15 per share, a year earlier. Total net sales reached $1,755.2 million, up from $1,582.5 million.
The quarter also included a non-cash deferred income tax benefit of $12.1 million ($0.28 per share) related to proposed currency regulations under §987, which should be weighed separately from operating performance.
Market Reaction and Investor Sentiment
Investor attention following the release centers on the durability of the chemicals turnaround. The swing from a $15.9 million segment loss to $60.5 million in operating income reflects both cyclical recovery in TiO2 pricing and structural factors such as anti-dumping duties and shifting supply conditions. Management noted that average TiO2 selling prices began 2026 below year-earlier levels but climbed 11% during the first nine months as price increases and surcharges took hold, with third-quarter prices 5% higher year over year. From what I see, the presence of a sizable non-cash tax benefit also means some investors may look through reported EPS to gauge underlying earnings quality, keeping sentiment tied to the trajectory of TiO2 pricing and demand rather than headline income alone.
Forward Outlook and Key Factors to Monitor
Looking ahead, the primary variable for VHI remains TiO2 pricing and demand across its key European and North American markets. The company has benefited from price increases and surcharges tied to rising energy and distribution costs, but the sustainability of these gains depends on whether end-market demand holds and whether competitors respond with capacity or pricing moves. Investors should also track currency effects, particularly the euro, which has boosted reported sales while pressuring operating income. A sustained stronger euro could continue to distort the relationship between top-line growth and profitability. On the cost side, energy and distribution expenses remain a swing factor, and the pace at which realized price increases offset these inputs will shape margins in future quarters. Within the broader portfolio, component products have shown steady improvement, while real estate activity is naturally tapering as development work nears completion, reducing a source of prior-period gains. Finally, because Valhi operates as a holding company, corporate expenses, interest costs, and tax items will continue to influence the earnings attributable to stockholders. Monitoring these non-operating items alongside core chemical profitability will be essential for assessing whether the current momentum can be maintained.
Using AI Tools in My Research
In my analysis of earnings-driven names like VHI, I often turn to Tickeron’s AI-powered tools to quickly compare peers and spot technical shifts. The AI Screener stands out for its ability to filter stocks by industry, patterns, and fundamentals, helping me validate ideas without spending hours on manual screens. It has become a regular part of how I cross-check sector trends after reports like this one.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
VHI's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for VHI turned positive on October 22, 2026. Looking at past instances where VHI's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VHI's RSI Indicator exited the oversold zone, 22 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on VHI as a result. In 71 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where VHI advanced for three days, in 191 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for VHI crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VHI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
VHI broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VHI entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.388) is normal, around the industry mean (1.198). P/E Ratio (-7.983) is within average values for comparable stocks, (3.263). Projected Growth (PEG Ratio) (0.100) is also within normal values, averaging (3.769). Dividend Yield (0.022) settles around the average of (0.190) among similar stocks. P/S Ratio (0.217) is also within normal values, averaging (0.578).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. VHI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VHI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company
Industry ChemicalsMajorDiversified
Advertisement